Abstract
For the purpose of reducing the adverse effect of antitumor drugs, a novel type of protease/redox/pH stimuli-responsive fluorescent porous silica (pSiO2) nanocarrier was designed. In this system, oxidized glutathione (GSSG), a kind of peptide with disulfide linkage, was grafted onto the pSiO2 nanospheres (NSs) via amido bonds. After that, acid-decomposable, luminescent ZnO quantum dots (QDs) were introduced to seal the nanopores of pSiO2 NSs via covalent attachment. The ZnO QDs behave as a dual-purpose entity that not only act as a fluorescence probe for drug-release monitoring but also play the role of gatekeeper that controls the drug release. The obtained ZnO-gated pSiO2-GSSG NSs delivery system would achieve minimized premature release under a physiological environment. The controlled release of the drug from the ZnO-gated delivery system was realized by the acidic dissolution of ZnO QDs, reduction of disulfide bonds and cleavage of the amino bonds, leading to ZnO falling off from the surface of pSiO2 NSs. The constructed ZnO-gated pSiO2-GSSG NSs delivery system has promising applications in site-specific drug release for tumor chemotherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
